Skip to main content

Table 2 Comparison of general information between PCOS patients and controls

From: Plasma level of peroxiredoxin 3 in patients with polycystic ovarian syndrome

 

Obesity (%)

BMI

FPG (mmoL/L)

FINS (mU/L)

HOMA-IR

PRX3 (ng/ml)

PCOS

52.0

28.9 ± 4.4

6.1 ± 1.2

18.7 ± 1.3

4.7 ± 0.2

29.5 ± 3.8

Control

10.7

23.2 ± 3.3

5.6 ± 0.5

11.2 ± 0.6

2.7 ± 0.1

29.3 ± 3.4

t (χ2) values

10.68

5.334

1.559

2.833

2.575

0.107

P values

0.001a

< 0.001a

0.119

0.005a

0.010a

0.915

  1. asignificant difference